A Boston University study found TB DNA in 12% to 16% of respiratory samples from hospitalized patients in a low-incidence area using an ultrasensitive assay, suggesting underdiagnosis of tuberculosis in the US.
Roche has launched the cobas eplex RP3 panel for CE-markets, enabling simultaneous detection of up to 25 respiratory pathogens with customizable configurations, according to the company.
Trinity Biotech has received final regulatory approval to transition upstream manufacturing of its Uni-Gold HIV rapid test to an offshore platform, a move expected to improve scalability and margins.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.
Nexus Medical Labs will implement Lybe Scientific’s NAxtra nucleic acid extraction kit in a 60,000-plus test unit deal to enhance high-throughput STI testing, citing improved detection limits and workflow efficiency.